| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in DTIL over the last quarter tilts toward buying: insiders added a net 4,744 shares worth roughly $30K. In the past 30 days, 1 insider bought and 0 sold. Purchases have clustered in the most recent filings.
Frankel Stanley (Director) stands out among recent buyers, now holding an estimated $249K in DTIL.
Classified under Biotechnology (Health Care sector), DTIL's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 573.9K | - | - | |
| CFO | 193.7K | - | - | |
| Other | 107.6K | - | - | |
| Other | 57.4K | - | - | |
| Dir | 47.5K | $298.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Frankel Stanley | Director | Buy | 1,000 | $6.00 | $6,000.00 | +2.5% | - | - | |
| Sep 25, 2026 | Brown Melinda58 | Director | Buy | 1,135 | $6.27 | $7,116.45 | +2.6% | - | - | |
| Sep 25, 2026 | Germano Geno J62 | Director | Buy | 2,609 | $6.28 | $16,384.52 | +5.8% | - | - | |
| Feb 18, 2026 | Amoroso Michael70 | President And CEO | Sale+OE | 20,559 | $3.84 | $78,946.56 | -7.8% | +79.2% | - | |
| Feb 18, 2026 | Scimeca Dario83 | General Counsel And Secretary | Sale+OE | 4,925 | $3.84 | $18,912.00 | -8.0% | +79.2% | - | |
| Feb 18, 2026 | Kelly John Alexander | Chief Financial Officer | Sale+OE | 8,149 | $3.84 | $31,292.16 | -6.1% | +79.2% | - | |
| Feb 18, 2026 | Smith J. Jefferson69 | Chief Research Officer | Sale+OE | 4,925 | $3.84 | $18,912.00 | -3.9% | +79.2% | - | |
| Jan 22, 2026 | Amoroso Michael70 | President And CEO | Sale+OE | 34,799 | $4.17 | $145,111.83 | -15.1% | +86.1% | - | |
| Jan 21, 2026 | Scimeca Dario83 | General Counsel And Secretary | Sale+OE | 8,854 | $4.03 | $35,681.62 | -16.5% | +85.5% | - | |
| Jan 21, 2026 | Kelly John Alexander | Chief Financial Officer | Sale+OE | 15,213 | $4.03 | $61,308.39 | -12.5% | +85.5% | - |